Archive for October, 2010

Terminal at 4-years-old, Triumphant at 22, Ryan Dant to Watch His Hero Nolan Ryan and His Beloved Rangers Take on Giants in Game 3

ARLINGTON, Texas, Oct. 30 /PRNewswire/ --Ryan Dant wasn't supposed to be a 22-year-old. Or an 18-year-old. Or even a 12-year-old. (Photo:  http://photos.prnewswire.com/prnh/20101029/CG91925 ) (Photo:  http://www.newscom.com/cgi-bin/prnh/20101029/CG91925 ) At three-and-a-half, the little...
READ THE FULL ARTICLE >>

Tuberous Sclerosis Alliance Announces FDA Approval of First Drug to Treat Tuberous Sclerosis Complex

SILVER SPRING, Md., Oct. 30 /PRNewswire/ -- The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA).  This drug, manufactured by Novartis Oncology, is called Afinitor and...
READ THE FULL ARTICLE >>

VIDEO from thenewsmarket.com and UNICEF: UNICEF and Partners Work to Keep a Cholera Outbreak at Bay in Haiti’s Capital

NEW YORK, Oct. 30 /PRNewswire/ -- See video from UNICEF: http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=be1e0208-d0b4-4ec3-9e20-3339913fcd52     UNICEF and its partners work closely with the government to urgently prepare in case there is a large outbreak in...
READ THE FULL ARTICLE >>

VIDEO from thenewsmarket.com and Ganeden Biotech: Feeling Good Inside and Out This Winter: Renowned Doctor Has Tips to Prevent Colds and Flus This Season

NEW YORK, Oct. 30 /PRNewswire/ -- See video from Ganeden Biotech: http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=b3987e9a-af2e-407c-9127-6c3fdb509f74     It is estimated that one billion colds occur annually in the U.S. and many people catch the flu, which leads to...
READ THE FULL ARTICLE >>

Week-24 Interim Results From Phase 2b PILLAR Study to be Presented as Late-Breaker at AASLD

BOSTON, Oct. 30 /PRNewswire/ -- Tibotec Pharmaceuticals (Tibotec) announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual...
READ THE FULL ARTICLE >>

Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon

BOSTON and RIDGEFIELD, Conn., Oct. 30, 2010 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI...
READ THE FULL ARTICLE >>

ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced the ANA598 data to be presented at the 61st Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston, MA.  ANA598, the Company's direct-acting antiviral...
READ THE FULL ARTICLE >>

Creating Functional Hepatic Tissue in a Bioengineered Human Liver

BOSTON, Oct. 30 /PRNewswire/ -- Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with...
READ THE FULL ARTICLE >>

Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes

BOSTON, Oct. 30 /PRNewswire/ -- Researchers from the University of Bari, Italy, concluded that treating patients after transplantation with antiviral therapy creates a sustained viral response (SVR) and protects them from liver-related deaths. The purpose of this study was to determine the...
READ THE FULL ARTICLE >>

Scientists Describe New Approach For Identifying Genetic Markers For Common Diseases

A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and...
READ THE FULL ARTICLE >>
Newer Entries »
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes